PancraGen® Clinical Utility Study Published in Diagnostic Pathology

Jan 28, 2016

Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts

Jan 20, 2016

Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp

Jan 12, 2016

Interpace Diagnostics Group Begins Trading on NASDAQ

Dec 23, 2015